| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 659991 | 69331 | PRAVASTATINA CODRAMOL 20 mg COMPRIMIDOS EFG | PRAVASTATINA CODRAMOL 20 mg COMPRIMIDOS EFG , 28 comprimidos | 20 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69331/69331_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69331/69331_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 8730 | FARMALIDER S.A. | 2007-10-16 | 1 | 1 | 1 | 2007-10-16 | 2007-10-16 | 1 | 2016-11-07 | View Edit Delete | ||||||||||||
| 659992 | 69332 | PRAVASTATINA CODRAMOL 40 mg COMPRIMIDOS EFG | PRAVASTATINA CODRAMOL 40 mg COMPRIMIDOS EFG , 28 comprimidos | 40 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69332/69332_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69332/69332_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 8730 | FARMALIDER S.A. | 2007-10-16 | 1 | 1 | 1 | 2007-10-16 | 2007-10-16 | 1 | 2016-11-07 | View Edit Delete | ||||||||||||
| 659988 | 69328 | NASALVICKS 0,5MG/ML SOLUCION PARA PULVERIZACIÓN NASAL | NASALVICKS 0,5MG/ML SOLUCION PARA PULVERIZACIÓN NASAL , 1 envase pulverizador de 15 ml | 0,5 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69328/69328_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69328/69328_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8994 | PROCTER & GAMBLE ESPANA S.A. | 2007-10-18 | 1 | 1 | 1 | 2007-11-05 | 2007-10-18 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659504 | 69076 | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 30 ml | 1 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69076/69076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69076/69076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-07-09 | 1 | 1 | 1 | 2007-07-09 | 2007-07-09 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 659505 | 69076 | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69076/69076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69076/69076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-07-09 | 1 | 1 | 1 | 2007-07-09 | 2007-07-09 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 659186 | 68875 | ESERTIA 20 mg/ml GOTAS ORALES EN SOLUCION | ESERTIA 20 mg/ml GOTAS ORALES EN SOLUCION, 1 frasco de 15 ml | 20 mg/ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68875/68875_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68875/68875_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | ALMIRALL S.A. | 2007-06-12 | 1 | 1 | 1 | 2007-06-12 | 2007-06-12 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659144 | 62114 | SICCAFLUID 2,5 mg/g GEL OFTALMICO | SICCAFLUID 2,5 mg/g GEL OFTALMICO , 1 tubo de 10 g | 2,5 mg/g | 6 | 10 | 21 | 1 tubo de 10 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62114/62114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62114/62114_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20729 | LABORATORIOS THEA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 1 | 2011-05-31 | View Edit Delete | ||||||||||||
| 659856 | 69265 | METOCLOPRAMIDA PENSA 1 mg/ml SOLUCION ORAL EFG | METOCLOPRAMIDA PENSA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 250 ml | 1 mg/ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69265/69265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69265/69265_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2007-09-19 | 1 | 1 | 1 | 2007-09-19 | 2007-09-19 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 660176 | 07436001 | ISENTRESS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ISENTRESS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 400 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07436001/07436001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07436001/07436001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2007-12-21 | 1 | 1 | 1 | 2007-12-21 | 2007-12-21 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 659981 | 62068 | OPTIRAY 300 mg/ml SOLUCION INYECTABLE | OPTIRAY 300 mg/ml SOLUCION INYECTABLE , 1 frasco de 500 ml | 300 mg/ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62068/62068_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62068/62068_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1240 | LABORATORIOS FARMACEUTICOS GUERBET S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 2007-10-10 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 658607 | 68535 | PRAVASTATINA QUALIGEN 10 mg COMPRIMIDOS EFG | PRAVASTATINA QUALIGEN 10 mg COMPRIMIDOS EFG , 28 comprimidos | 10 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68535/68535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68535/68535_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 658608 | 68536 | PRAVASTATINA QUALIGEN 20 mg COMPRIMIDOS EFG | PRAVASTATINA QUALIGEN 20 mg COMPRIMIDOS EFG , 28 comprimidos | 20 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68536/68536_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68536/68536_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 658610 | 68537 | PRAVASTATINA QUALIGEN 40 mg COMPRIMIDOS EFG | PRAVASTATINA QUALIGEN 40 mg COMPRIMIDOS EFG , 28 comprimidos | 40 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68537/68537_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68537/68537_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659755 | 62096 | RISPERDAL 1 mg/ ml SOLUCION ORAL | RISPERDAL 1 mg/ ml SOLUCION ORAL , 1 frasco de 30 ml | 1 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62096/62096_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62096/62096_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1998-09-01 | 1 | 1 | 1 | 1998-09-01 | 1998-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659813 | 62096 | RISPERDAL 1 mg/ ml SOLUCION ORAL | RISPERDAL 1 mg/ ml SOLUCION ORAL , 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62096/62096_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62096/62096_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1998-09-01 | 1 | 1 | 1 | 1998-09-01 | 1998-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 660259 | 99123012 | RENAGEL 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RENAGEL 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 180 comprimidos | 800 mg | 6 | 180 | 10 | 180 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99123012/99123012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99123012/99123012_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2008-03-25 | 1 | 1 | 1 | 2008-03-25 | 2008-03-25 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 658697 | 06379001 | CYSTADANE 1 g POLVO ORAL | CYSTADANE 1 g POLVO ORAL , 1 frasco de 180 g + 3 cucharas graduadas | 1 g/g | 6 | 180 | 21 | 1 frasco de 180 g + 3 cucharas graduadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06379001/06379001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06379001/06379001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 0 | 2011-05-10 | View Edit Delete | ||||||||||||
| 659150 | 68861 | OMEPRAZOL DAVUR 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL DAVUR 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68861/68861_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68861/68861_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-05-31 | 1 | 1 | 1 | 2007-05-31 | 2007-05-31 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 659154 | 68863 | BELMAZOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES | BELMAZOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68863/68863_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68863/68863_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-05-31 | 1 | 1 | 1 | 2007-05-31 | 2007-05-31 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 659175 | 00160065 | AERIUS 0,5 MG/ML SOLUCION ORAL | AERIUS 0,5 MG/ML SOLUCION ORAL , 1 frasco de 120 ml | 0,5 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00160065/00160065_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00160065/00160065_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ORGANON SALUD S.L. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2007-07-02 | 1 | 2012-01-02 | View Edit Delete |
Page 152 of 1036, showing 20 records out of 20704 total, starting on record 3021, ending on 3040